Tablets Under Recall for Undeclared Drug Ingredient

All lots of the dietary supplement Artri King are voluntarily being recalled by Botanical-Be, according to the December 6, 2023, US Food and Drug Administration (FDA) Enforcement Report. The company initiated the recall after the FDA identified diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), in Artri King and two other products.

“Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses,” Botanical-Be stated in a November 7, 2023, company announcement.

The recall affects all Artri King tablets (UPC 7 501031 111138), which are packaged in 100-count bottles. The tablets were manufactured by Plantas medicinales de Mexico, Xochimilco, Mexico, sold online, and distributed throughout the US.

Botanical-Be initiated its recall October 20, 2023. The recall has not yet been classified by the FDA.

Artri King is marketed as a dietary supplement for the relief of pain and inflammation associated with arthritis.